‹

News & Bulletin UpdatesNews

INDIA DOMESTIC PRICES – WHAT IS GOING ON?

RSS prices ease slightly after recent recovery while fortnightly gains remain intact – India Domestic Prices – What Is Going On?

IndianPetroChem

This edition covers:

  • Ortho-Xylene prices retreat sharply this week despite broader three-month recovery remaining intact
  • Benzyl Alcohol prices ease weekly while strong fortnightly recovery remains firmly intact
  • Ethylene Glycol Monoethyl Ether Acetate prices extend steady weekly and monthly gains
  • Diethylene Glycol Monobutyl Ether prices edge higher despite sharp fortnightly decline overall
  • Toluene prices ease weekly but remain firmly above last month's levels overall
  • Perchloroethylene prices retreat weekly despite maintaining modest monthly and three-month gains overall
  • Trichloroethylene prices surge weekly as strong monthly gains push toward recent highs
  • Methyl Ethyl Ketone prices extend weekly decline as fortnightly losses deepen further
  • Methyl Isobutyl Ketone prices ease slightly after recent weekly gains remain intact
  • Phenol prices retreat sharply from recent highs despite strong monthly gains overall
  • Caprolactam prices surge to one-year high after strong weekly and monthly gains
  • Aniline prices climb steadily as weekly gains reinforce strong monthly recovery trend
  • PVC prices hold steady near recent highs after firm monthly gains continue
  • PS prices retreat sharply this week despite strong monthly gains remaining intact
  • EVA prices hold steady as modest monthly recovery remains intact in Mumbai
  • Fumed Silica prices extend fortnightly recovery while holding near recent high levels
  • Ethanol prices climb further as weekly and fortnightly gains strengthen market momentum
  • Wet Slurry prices extend monthly decline despite slight fortnightly recovery remaining intact
  • RSS prices ease slightly after recent recovery while fortnightly gains remain intact

The complete bulletin is available to subscribers.

Read the complete bulletin

Request a free trial and our team will set up your access. Subscribers log in and return to this bulletin in full.

Questions about access? Contact our team
← Browse more news & analysis